🇺🇸 dicrofenac and travoprost in United States

dicrofenac and travoprost (dicrofenac and travoprost) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

dicrofenac and travoprost in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is dicrofenac and travoprost approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for dicrofenac and travoprost in United States?

Tokyo University is the originator. The local marketing authorisation holder may differ — check the official source linked above.